ENJOY Science Seminar Series

---

RSS

Occurs every 2 weeks on Thursday starting on 1/9/2025 at 10:00 AM
Thursday, January 9, 2025, 10:00 AM - 11:00 AM, Virtual


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

The Translational Research ENJOY SCIENCE Seminar Series will explore breakthroughs in targeted therapies, immunotherapies, and personalized medicine approaches and showcase how MD Anderson's research community is pushing the boundaries of scientific knowledge, translating discoveries from the laboratory into life-changing treatments. Through interactive sessions and thought-provoking discussions, learners will have the chance to explore emerging trends, address challenges, and envision the future of cancer care. Collaboration with peers, shared experiences, and forged connections will fuel professional growth and inspire new avenues of exploration. This continuing medical education activity is a unique opportunity to elevate one's knowledge, gain invaluable insights, and be part of the vanguard driving transformative change in oncology. Unlocking the frontiers of cancer research, where hope and innovation converge to shape a brighter future for patients worldwide.

1. Discuss the latest advancements and emerging technologies in the field of molecular pathology.
2. Identify opportunities for interdisciplinary collaboration between researchers and clinicians to translate innovative discoveries into clinical practice.
3. Develop a framework for implementing translational molecular pathology approaches in clinical settings, considering ethical, regulatory, and practical considerations.

If you are interested in attending this series,  contact Ebonie Hatfield, Activity Coordinator, [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.